We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes

This study has been terminated.
(Research site no longer available)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01755312
First Posted: December 24, 2012
Last Update Posted: August 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Alan Zillich Lab, Purdue University
  Purpose
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed

Condition Intervention
Medication Adherence Blood Pressure Device: Medication reminder

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Effect of Medication Reminder Technology on Medication Adherence and Hypertension

Further study details as provided by Alan Zillich Lab, Purdue University:

Primary Outcome Measures:
  • self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • systolic blood pressure in mmHg using a valid automated device [ Time Frame: 6 months ]

Enrollment: 28
Study Start Date: June 2013
Study Completion Date: January 2015
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: medication reminder
medication reminder
Device: Medication reminder
Medication reminder
Placebo Comparator: Placebo
Placebo

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • poor medication adherence
  • high blood pressure

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01755312


Locations
United States, Indiana
Purdue University
West Lafayette, Indiana, United States, 47906
Sponsors and Collaborators
Purdue University
  More Information

Responsible Party: Alan Zillich Lab, Associate Professor Pharmacy Practice, Purdue University
ClinicalTrials.gov Identifier: NCT01755312     History of Changes
Other Study ID Numbers: 2r44ago39178-02 (1208012596)
First Submitted: December 18, 2012
First Posted: December 24, 2012
Last Update Posted: August 27, 2015
Last Verified: August 2015

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases